Daizo Kishino

Phase II Trial of Gefitinib in Combination with Bevacizumab as First-Line Therapy for Advanced Non–Small Cell Lung Cancer with Activating EGFR Gene Mutations: The Okayama Lung Cancer Study Group Trial 1001

Eiki Ichihara, Katsuyuki Hotta, Naoyuki Nogami et al. · Journal of Thoracic Oncology · 2015 · 104 citations

Medicine, Oncology, Pharmacology +12

Bronchiolitis obliterans organizing pneumonia syndrome in breast-conserving therapy for early breast cancer: Radiation-induced lung toxicity

Nagio Takigawa, Yoshihiko Segawa, Toshiaki Saeki et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 94 citations

Medicine, Oncology, Radiation Oncology +17

The impact of body mass index on the efficacy of anti-PD-1/PD-L1 antibodies in patients with non-small cell lung cancer

Eiki Ichihara, Daijiro Harada, Koji Inoue et al. · Lung Cancer · 2019 · 89 citations

Medicine, Immunology, Oncology +16

The effects of antibiotics on the efficacy of immune checkpoint inhibitors in patients with non–small-cell lung cancer differ based on PD-L1 expression

Nobuaki Ochi, Eiki Ichihara, Nagio Takigawa et al. · European Journal of Cancer · 2021 · 68 citations

Medicine, Immunology, Oncology +13

Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis?

Yoshiko Ogata, Keisuke Aoe, Akio Hiraki et al. · PubMed · 2011 · 42 citations · Full text

Medicine, Internal Medicine, Pathology +16